Lumify

Active Ingredient(s): Brimonidine Tartrate
FDA Approved: * December 22, 2017
Pharm Company: * BAUSCH AND LOMB INC
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Lumify Overview

Brimonidine is a drug used as eye drops under the brand names Alphagan and Alphagan-P to treat open-angle glaucoma or ocular hypertension, and as a gel, Mirvaso, for facial skin redness in rosacea. It acts via decreasing synthesis of aqueous humor, and increasing the amount that drains from the eye through uveoscleral outflow; brimonidine treats reddened skin (erythema) by causing narrowing of blood vessels (vasoconstriction). Contents 1 Clinical uses 2 Mechanism of action 3 References...

Read more Lumify Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Brimonidine

Recent Lumify Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Brimonidine Tartrate
  • Drops: 0.2%
  • Gel: 0.33%
  • Solution: 0.15%, 0.2%
  • Solution/drops: 0.025%, 0.1%, 0.10%, 0.15%, 0.2%, 0.20%, 0.5%, 0.50%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Brimonidine Tartrate or a similar ingredient: (8 results)





Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2018 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 22 February 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.